-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transplant Options and Outcomes for TP53 Myeloid Disease

Program: Education Program
Session: Handling Bad News: How to Best Manage TP53 Myeloid Disease
Hematology Disease Topics & Pathways:
Therapy sequence, Treatment Considerations
Saturday, December 7, 2024, 4:00 PM-5:15 PM

Hugo Francisco Fernandez, MD

Moffitt Malignant Hematology and Cellular Therapy, Pembroke Pines, FL

Disclosures: No relevant conflicts of interest to declare.

See more of: Handling Bad News: How to Best Manage TP53 Myeloid Disease
See more of: Education Program
<< Previous Presentation | Next Presentation